REQUEST A DEMO
Total
USD $0.00
Search more companies

Sager Pharma Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: SAGER Pharma Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Sager Pharma (Hungary) offers a variety of medications and products for rheumatological pathologies, pain relief, eye dryness, and throat disinfection, including nasal sprays, local pain patches, oral medications, and eye medications. They also distribute the Japanese pain treatment product, SALONPAS, developed by Hisamitsu. Sager Pharma (Hungary) aims to expand its presence in the Central European pharmaceutical markets in the next five years.

Headquarters
Pasareti ut 122-124. B. ep. fszt. 1.
Budapest; Budapest; Postal Code: 1026

Contact Details: Purchase the Sager Pharma Kft. report to view the information.

Website: http://www.sagerpharma.hu

Basic Information
Total Employees:
Purchase the Sager Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Sager Pharma Kft. report to view the information.
Registered Capital:
Purchase the Sager Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Sager Pharma Kft. report to view the information.
Incorporation Date:
April 04, 2006
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Sager Pharma Kft.
Company Performance
Financial values in the chart are available after Sager Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.97%
Total operating revenue
11.77%
Operating profit (EBIT)
40.05%
EBITDA
38.92%
Net Profit (Loss) for the Period
50.04%
Total assets
28.36%
Total equity
49.55%
Operating Profit Margin (ROS)
2.93%
Net Profit Margin
3.68%
Return on Equity (ROE)
0.32%
Quick Ratio
0.2%
Cash Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?